544611 MAHALIFE

Mahamaya Lifesciences Share Price

 

 

Start SIP in MAHALIFE

Start SIP

Performance

  • Low
  • ₹133
  • High
  • ₹151
  • 52 Week Low
  • ₹111
  • 52 Week High
  • ₹151
  • Open Price₹136
  • Previous Close₹133
  • Volume121,200

Investment Returns

Smart Investing Starts Here Start SIP with Mahamaya Lifesciences for Steady Growth!

Invest Now

Mahamaya Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 26.6
  • PEG Ratio
  • -
  • Market Cap Cr
  • 344
  • P/B Ratio
  • Average True Range
  • -
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • -
  • MFI
  • -

Mahamaya Lifesciences Financials

Mahamaya Lifesciences Technicals

EMA & SMA

Current Price
₹147.00
+ 14 (10.53%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 5
  • 20 Day
  • -
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

143.75 Pivot Speed
  • R3 172.50
  • R2 161.75
  • R1 154.50
  • S1 136.50
  • S2 125.75
  • S3 118.50

Mahamaya Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-12-02 Half Yearly Results

Mahamaya Lifesciences F&O

Mahamaya Lifesciences Shareholding Pattern

56.35%
0.95%
6.39%
12.72%
23.59%

About Mahamaya Lifesciences

  • NSE Symbol
  • MAHALIFE
  • BSE Symbol
  • 544611
  • Managing Director
  • Mr. Krishnamurthy Ganesan
  • ISIN
  • INE0U9D01019

Similar Stocks to Mahamaya Lifesciences

Mahamaya Lifesciences FAQs

Mahamaya Lifesciences share price is ₹147 As on 07 December, 2025 | 09:35

The Market Cap of Mahamaya Lifesciences is ₹344.1 Cr As on 07 December, 2025 | 09:35

The P/E ratio of Mahamaya Lifesciences is 26.6 As on 07 December, 2025 | 09:35

The PB ratio of Mahamaya Lifesciences is 5.8 As on 07 December, 2025 | 09:35

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23